References
- Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base No 11 [Internet] Lyon. Fr Int Agency Res Cancer. 2013;2013.
- Zehnder P, Moltzahn F, Daneshmand S, et al. Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy. BJU Int. 2014;113(1):65–69.
- Reyes MC, Park KJ, Lin O, et al. Urothelial carcinoma involving the gynecologic tract: a morphologic and immunohistochemical study of 6 cases. Am J Surg Pathol. 2012;36:1058–1065.
- Koyanagi Y, Kubo C, Nagata S, et al. Detection of pagetoid urothelial intraepithelial neoplasia extending to the vagina by cervical screening cytology: a case report with renewed immunochemical summary. Diagn Pathol. 2019;14(1):9.
- Wilkinson EJ, Brown HM. Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol. 2002;33 :549–554.
- Aoun F, Kourie HR, El Rassy E, et al. Bladder and vaginal transitional cell carcinoma: a case report. Oncol Lett. 2016;12:2181–2183.
- Morbeck D, Tregnago AC, Netto GB, et al. GATA3 expression in primary vulvar Paget disease: a potential pitfall leading to misdiagnosis of pagetoid urothelial intraepithelial neoplasia. Histopathology. 2017;70(3):435–441.
- Brown HM, Wilkinson EJ. Uroplakin-III to distinguish primary vulvar Paget disease from Paget disease secondary to urothelial carcinoma. Hum Pathol. 2002;33:545–548.
- Padhy RR, Nasseri-Nik N, Abbas F. Poorly differentiated high-grade urothelial carcinoma presenting as Paget’s disease of the vulva with no overt urinary tract neoplasm detected. Gynecol Oncol Rep. 2017;20:70–72.
- Gregori CA, Smith CI, Breen JL. Extramammary Paget's disease. Clin Obstet Gynecol. 1978 Dec;21(4):1107–15. doi: 10.1097/00003081-197821040-00014. PMID: 216512
- St Claire K, Hoover A, Ashack K, Khachemoune A. Extramammary Paget disease. Dermatol Online J. 2019 Apr 15;25(4):13030/qt7qg8g292. PMID: 31046904.